Arca
Skip to content
Tools
Tools

Ventavis (iloprost) Inhalation Solution

Recall D-143-2013, part of FDA recall event 64151. See Actelion Pharmaceuticals U.S.'s company page.

Actelion Pharmaceuticals U.S., Inc. started this Class III drug recall on Jan 16, 2013 (voluntary: firm initiated); FDA lists it as terminated, terminated Jul 23, 2013.

  • Classification: Class III
  • Started: Jan 16, 2013
  • Status: Terminated

Why It Was Recalled

Class III

Subpotent Drug: OOS (out of specification) assay result at the 12 month stability time point.

Record

Product
Ventavis (iloprost) Inhalation Solution, 10 mcg/1 mL, Sterile, 30 Single Use Ampules per carton, Manufactured for Actelion Pharmaceuticals US, Inc, 5000 Shoreline Court, Ste 200, South San Francisco, CA 94080, NDC: 66215-302-30.
Quantity
3 Cartons
Lots and codes
Lot #: MA00AD5, Exp: 11/30/2014
Distribution
CA & VA
Recalling firm
Actelion Pharmaceuticals U.S., Inc., South San Francisco, CA, United States
How the firm notified
Letter
FDA classified
Feb 1, 2013

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.